Navigation Links
Moffitt Selects Microsoft's Azyxxi to Help Drive Personalized Cancer Treatment
Date:9/20/2007

Software to save years in research that aligns patients and treatments.

REDMOND, Wash. and TAMPA, Fla., Sept. 20 /PRNewswire-FirstCall/ -- The H. Lee Moffitt Cancer Center & Research Institute has selected Azyxxi(R), the Microsoft(R) unified health enterprise platform, to aid in its development of personalized cancer treatment programs. Azyxxi will be used to assimilate large quantities of diverse data, including electrocardiograms, magnetic resonance imaging scans, dynamic angiograms, ultrasound images and, ultimately, genomic information, providing a visual gateway for instant access to the information, and allowing researchers to make and prove their hypotheses within minutes instead of months.

(Logo: http://www.newscom.com/cgi-bin/prnh/20000822/MSFTLOGO)

"After searching for two years, we selected Azyxxi because we believe it provides the healthcare and research context that other products in the marketplace just don't offer," said Ed Martinez, chief information officer at Moffitt. "As a product developed by physicians, Azyxxi works the way clinicians and researchers work. It provides rapid results with minimum clicks, and allows for specific queries to help analyze and visualize data."

Personalized medicine holds the promise to better align patients with treatment programs. Azyxxi will help in the mining of data that allows Moffitt to make appropriate clinical and scientific discoveries, setting the stage for relating genetic information to clinical practice.

"Azyxxi's ability to correlate information and present it in a cohesive way can help any health organization tackle almost any challenge, and this is another great example of that," said Peter Neupert, corporate vice president of the Health Solutions Group at Microsoft Corp. "We are thrilled that Moffitt recognizes Azyxxi as a tool that can help its researchers, clinicians -- and ultimately patients -- not only in the Moffitt Cancer Center but across the state of Florida."

About Moffitt Cancer Center

Located in Tampa, Florida, Moffitt Cancer Center (http://www.moffitt.org) is the only Florida-based cancer center with the NCI designation as a Comprehensive Cancer Center for its excellence in research and contributions to clinical trials, prevention and cancer control. Moffitt currently has 15 affiliates in Florida, one in Georgia and two in Puerto Rico. Additionally, Moffitt is a member of the National Comprehensive Cancer Network, a prestigious alliance of the country's leading cancer centers, and is listed in U.S. News & World Report as one of "America's Best Hospitals" for cancer and ear, nose and throat. Moffitt's sole mission is to contribute to the prevention and cure of cancer.

About Microsoft

Founded in 1975, Microsoft (Nasdaq: MSFT) is the worldwide leader in software, services and solutions that help people and businesses realize their full potential.


'/>"/>
SOURCE Microsoft Corp.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. United States Department of Defense Selects Ichor Medical Systems to Develop Biodefense Vaccine
2. Sleepy drivers increase road death toll
3. Traffic Violations Result in Safer Drivers
4. Dyslexia may slow a drivers reaction time as much as moderate drinking!!
5. Study suggests symptom driven therapy for adults with asthma
6. Peppermint or cinnamon smell can make drivers more alert
7. Mechanical forces drive early heart development
8. Measles Vaccination Drive Intensified In Quake-Hit Pakistan
9. More Funds Are Required For Immunisation Drive
10. Both Kidneys Robbed From A Poor Rickshaw Driver In Bihar
11. High Prevalence of AIDS among Indian Truck drivers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/20/2017)... , ... July 20, 2017 , ... Team Type 1 ... to medicine for everyone affected by diabetes, is teaming up with a Microsoft Corp. ... event kicks off on July 24th. , “Team Type 1’s mission overlaps seamlessly ...
(Date:7/20/2017)... ... , ... The Dermatology Clinic announced today the addition of Dr. Scott W. ... LSU, graduating summa cum laude. He attended Emory University School of Medicine in Atlanta ... Dr. Dunbar moved to New York to complete an AGCME-accredited Mohs surgery fellowship to ...
(Date:7/20/2017)... ... July 20, 2017 , ... A budget proposal to switch to an alternate ... - adjustment (COLA) is a bad deal for older and disabled Americans, says ... would grow even more slowly than the conventional one that is currently used to ...
(Date:7/20/2017)... ... July 19, 2017 , ... Med Tech Solutions (MTS), a leading health ... business unit of Constellation Inc., a move that will help the company better serve ... St. Louis, the acquisition is expected to help MTS expand its presence ...
(Date:7/20/2017)... ... 2017 , ... “Fidget”: a fun-filled, action-packed memoir of adventures. “Fidget” is the ... drama teacher who was a summa cum laude graduate of Gardner Webb University. She ... award. After her retirement from public school, Lynn continued to pursue her love for ...
Breaking Medicine News(10 mins):
(Date:7/11/2017)... ROCKVILLE, Md. , July 11, 2017  The ... had estimated revenues of approximately $394.1 million in 2016.  ... a trend of solid growth, in particular as a ... oncology clinical practice, and the recent introduction of a ... the need for less-invasive testing of tumor biomarkers to ...
(Date:7/10/2017)... 10, 2017 The Institute for In Vitro ... the recipient of a VITROCELL® inhalation exposure system thanks ... Consortium. The device, which is designed to replace animals ... lung cells to airborne test materials in an environment ... VITROCELL® system for testing combustible tobacco products, as well ...
(Date:7/5/2017)... -- Wolfmet 3D  printed tungsten collimator manufactured by M&I Materials proves ... to progress molecular radiotherapy imaging. In molecular radiotherapy ... accurately quantify the radiation absorbed by those patients undergoing treatment. ... this radiotherapy treatment has been available — that is, until ... ...
Breaking Medicine Technology: